These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 2105682)

  • 1. Thrombolytic therapy in canine pulmonary embolism. Comparative effects of urokinase and recombinant tissue plasminogen activator.
    Prewitt RM; Hoy C; Kong A; Gu SA; Greenberg D; Cook R; Chan SM; Ducas J
    Am Rev Respir Dis; 1990 Feb; 141(2):290-5. PubMed ID: 2105682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary thrombolysis. Comparative effects of intracoronary administration of recombinant tissue plasminogen activator and urokinase.
    Gu S; Ducas J; Patton JN; Greenberg D; Prewitt RM
    Chest; 1992 Jun; 101(6):1684-90. PubMed ID: 1600792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of flow on recombinant tissue plasminogen activator-induced pulmonary thrombolysis.
    Prewitt RM; Gu SA; Greenberg D; Chan SM; Schick U; La Pointe H; Ducas J
    J Appl Physiol (1985); 1991 Oct; 71(4):1441-6. PubMed ID: 1757368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Principles of thrombolysis in pulmonary embolism.
    Prewitt RM
    Chest; 1991 Apr; 99(4 Suppl):157S-164S. PubMed ID: 2009813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of low-molecular-weight heparin on recombinant tissue plasminogen activator-induced thrombolysis in canine pulmonary embolism.
    Werier J; Ducas J; Gu S; Chan SM; Prewitt RM
    Chest; 1991 Aug; 100(2):464-9. PubMed ID: 1650681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental study of the thrombolytic effects in a canine model of pulmonary thromboembolism induced by autologous radioactive blood clots].
    Wang F; Wang C; Wang T; Pang BS; Wu YB; Yang YH; Li C; Zhang HY; Weng XZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Feb; 27(2):93-6. PubMed ID: 14990182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of hydralazine and increased cardiac output on recombinant tissue plasminogen activator-induced thrombolysis in canine pulmonary embolism.
    Prewitt RM; Downes AM; Gu SA; Chan SM; Ducas J
    Chest; 1991 Mar; 99(3):708-14. PubMed ID: 1899825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pulmonary embolism: which thrombolytic should be chosen?].
    Pacouret G; Augusseau-Richard MP; Dessenne X; Pagot O; Charbonnier B
    Arch Mal Coeur Vaiss; 1995 Nov; 88(11 Suppl):1763-7. PubMed ID: 8815837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant tissue-type plasminogen activator in canine embolic pulmonary hypertension. Effects of bolus versus short-term administration on dynamics of thrombolysis and on pulmonary vascular pressure-flow characteristics.
    Prewitt RM; Shiffman F; Greenberg D; Cook R; Ducas J
    Circulation; 1989 Apr; 79(4):929-38. PubMed ID: 2494007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue plasminogen activator in acute pulmonary embolism.
    Goldhaber SZ
    Chest; 1989 May; 95(5 Suppl):282S-289S. PubMed ID: 2495913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous administration of recombinant tissue plasminogen activator. Optimizing the rate of coronary thrombolysis.
    Prewitt RM; Gu S; Schick U; Ducas J
    Chest; 1995 Apr; 107(4):1146-51. PubMed ID: 7705128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The value of thrombolysis for the treatment of acute pulmonary embolism].
    Marbet GA
    Schweiz Med Wochenschr; 1989 Oct; 119(43):1498-505. PubMed ID: 2514456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The thrombolytic treatment of acute and subacute recurrent pulmonary embolism with recombinant tissue plasminogen activator].
    Tiede N; Kasper W; Geibel A; Bassenge D; Langenstein B; Meinertz T; Just H
    Dtsch Med Wochenschr; 1990 Nov; 115(45):1699-704. PubMed ID: 2121453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing coronary thrombolysis with i.v. administration of recombinant tissue plasminogen activator. Single bolus vs double bolus vs front-loading.
    Prewitt RM; Schick U; Ducas J
    Chest; 1996 Feb; 109(2):510-5. PubMed ID: 8620730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated ST-segment reduction after thrombolytic therapy with recombinant tissue plasminogen activator (rtPA) compared to urokinase.
    Derad I; Stierle U; Giannitsis E; Potratz J; Born J; Djonlagic H; Fehm HL
    Jpn Heart J; 1996 Jan; 37(1):33-41. PubMed ID: 8632624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of recombinant single-chain urokinase-type plasminogen activator on experimental pulmonary embolism.
    Yang Wang ; Chen Wang ; Yuanhua Yang ; Baosen Pang
    Clin Appl Thromb Hemost; 2010 Oct; 16(5):537-42. PubMed ID: 19833628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant tissue plasminogen activator versus urokinase for local thrombolysis of femoropopliteal occlusions: a prospective, randomized multicenter trial.
    Mahler F; Schneider E; Hess H;
    J Endovasc Ther; 2001 Dec; 8(6):638-47. PubMed ID: 11797982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of transthoracic echocardiography in therapy regimens evaluation in pulmonary embolism.
    Zhu L; Wang C; Yang Y; Wu Y; Zhai Z; Dai H; Pang B; Tong Z
    J Thromb Thrombolysis; 2008 Dec; 26(3):251-6. PubMed ID: 17705052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of recombinant tissue-type plasminogen activator on life-threatening acute pulmonary thromboembolism in a canine model: a comparative study of e6010 and alteplase.
    Tagami H; Utoh J; Sun LB; Okamoto K; Moriyama S; Kunitomo R; Kitamura N
    Ann Thorac Cardiovasc Surg; 2000 Oct; 6(5):299-303. PubMed ID: 11173335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial.
    Goldhaber SZ; Kessler CM; Heit JA; Elliott CG; Friedenberg WR; Heiselman DE; Wilson DB; Parker JA; Bennett D; Feldstein ML
    J Am Coll Cardiol; 1992 Jul; 20(1):24-30. PubMed ID: 1607532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.